Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies

Vaccine

Volumn 17, Issue 17, 1999, Pages 2129-2135

  Rose, Robert C ^a   Lane, Christopher ^a   Wilson, Susan ^b   Suzich, Joann A ^b   Rybicki, Edward ^c   Williamson, Anna Lise ^c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b MEDIMMUNE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cervical cancer; Condyloma acuminatum; HPV; Oral vaccine; Papillomavirus; Virus like particles; VLPs

Indexed keywords

VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOPROPHYLAXIS; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WART VIRUS;

EID: 0033597104     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00484-8     Document Type: Article

References (40)

1. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Micro. Immuno. 186:1994;131-156.
2. Anonymous. National Institutes of Health National institutes of health consensus development conference statement on cervical cancer. Gynecologic Oncology. 66:1997;351-361.
3. Kirnbauer R., Booy F., Cheng N., Lowy D.R., Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. PNAS USA. 89:1992;12180-12184.
4. Rose R.C., Bonnez W., Reichman R.C., Garcea R.L. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. Journal of Virology. 67:1993;1936-1944.
5. Rose R.C., Reichman R.C., Bonnez W. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. Journal of General Virology. 75(8):1994;2075-2079.
6. Christensen N.D., Hopfl R., DiAngelo S.L., Cladel N.M., Patrick S.D., Welsh P.A., Budgeon L.R., Reed C.A., Kreider J.W. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. Journal of General Virology. 75(9):1994;2271-2276.
7. Suzich J.A., Ghim S.J., Palmer-Hill F.J., White W.I., Tamura J.K., Bell J.A., Newsome J.A., Jenson A.B., Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. PNAS USA. 92:1995;11553-11557.
8. Breitburd F., Kirnbauer R., Hubbert N.L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G., Schiller J.T., Lowy D.R. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. Journal of Virology. 69:1995;3959-3963.
9. Kirnbauer R., Chandrachud L.M., O'Neil B.W., Wagner E.R., Grindlay G.J., Armstrong A., McGarvie G.M., Schiller J.T., Lowy D.R., Campo M.S. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology. 219:1996;37-44.
10. Munos N. Disease-burden related to cancer induced by human viruses and H. pylori. World Health Organization (WHO) Vaccine Research and Development: Report of the Technical Review Group Meeting, 9-10 June, 1997.
11. Arntzen C.J. Pharmaceutical foodstuffs: oral immunization with transgenic plants [news]. Nature Medicine. 4:1998;502-503.
12. Oneal C.M., Crawford S.E., Estes M.K., Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. Journal of Virology. 71:1997;8707-8717.
13. Ball J.M., Hardy M.E., Atmar R.L., Conner M.E., Estes M.K. Oral immunization with recombinant norwalk virus-like particles induces a systemic and mucosal immune response in mice. Journal of Virology. 72:1998;1345-1353.
14. Rose R.C., Bonnez W., Strike D.G., Reichman R.C. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles. Journal of General Virology. 71(11):1990;2725-2729.
15. Rose R.C., Bonnez W., Da Rin C., McCance D.J., Reichman R.C. Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles. Journal of General Virology. 75(9):1994;2445-2449.
16. Li M., Cripe T.P., Estes P.A., Lyon M.K., Rose R.C., Garcea R.L. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA-binding and capsid assembly. Journal of Virology. 71:1997;2988-2995.
17. Dillner L., Heino P., Moreno-Lopez J., Dillner J. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine and avian papillomaviruses. Journal of Virology. 65:1991;6862-6871.
18. Smith L.H., Foster C., Hitchcock M.E., Leiserowitz G.S., Hall K., Isseroff R., Christensen N.D., Kreider J.W. Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. Journal of Investigative Dermatology. 105:1995;438-444.
19. Rose R.C., White W.I., Li M., Suzich J.A., Lane C., Garcea R.L. Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies. Journal of Virology. 72(7):1998;6151-6154.
20. Gray J.J., Cunliffe C., Ball J., Graham D.Y., Desselberger U., Estes M.K. Detection of immunoglobulin M (IgM), IgA and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. Journal of Clinical Microbiology. 32:1994;3059-3063.
21. Christensen N.D., Kreider J.W. Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes on intact virions. Virus Research. 21:1991;169-179.
22. Roden R.B., Hubbert N.L., Kirnbauer R., Christensen N.D., Lowy D.R., Schiller J.T. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. Journal of Virology. 70:1996;3298-3301.
23. Rose R.C., Greer C., Bonnez W., Ralston R., Reichman R.C. Antigenic cross-reactivity between HPV-6 and HPV-11. 13th International Papillomavirus Conference, Amsterdam, The Netherlands 1994.
24. Schiller J.T., Lowy D.R. Papillomavirus-like particles and HPV vaccine development. Seminars in Cancer Biology. 7:1996;373-382.
25. Kirnbauer R. Papillomavirus-like particles for serology and vaccine development. Intervirology. 39:1996;54-61.
26. Rose R.C., Bonnez W., Reichman R.C. Human papillomavirus infections. In: Galasso G.J., Whitley R.J., Merigan T.C., editors. Antiviral agents and human viral diseases. Philadelphia: Lippincott-Raven Publishers, 1997. p. 343-68.
27. Hines J.F., Ghim S.J., Jenson A.B. Prospects for human papillomavirus vaccine development: emerging HPV vaccines. Curr. Op. Inf. Dis. 11:1998;57-61.
28. Christensen N.D., Kirnbauer R., Schiller J.T., Ghim S.J., Schlegel R., Jenson A.B., Kreider J.W. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virol. 205:1994;329-335.
29. White W.I., Wilson S.D., Bonnez W., Rose R.C., Koenig S., Suzich J.A. In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. Journal of Virology. 72(2):1998;959-964.
30. Neutra M.R., Pringault E., Kraehenbuhl J.P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Ann. Rev. Immuno. 14:1996;275-300.
31. Wolf J.L., Rubin D.H., Finberg R., Kauffman R.S., Sharpe A.H., Trier J.S., Fields B.N. Intestinal M-cells: a pathway for entry of reovirus into the host. Science. 212:1981;471-472.
32. Buller C.R., Moxley R.A. Natural infection of porcine ileal dome M-cells with rotavirus and enteric adenovirus. Veterinary Pathology. 25:1988;516-517.
33. Inman L.R., Cantey J.R. Specific adherence of Escherichia coli (strain RDEC-1) to membranous (M) cells of the Peyer's patch in Escherichia coli diarrhea in the rabbit. Journal of Clinical Investigation. 71:1983;1-8.
34. Keren D.F., McDonald R.A., Wassef J.S., Armstrong L.R., Brown J.E. The enteric immune response to shigella antigens. Curr. Top. Micro. Immuno. 146:1989;213-223.
35. Amerongen H.M., Weltzin R., Farnet C.M., Michetti P., Haseltine W.A., Neutra M.R. Transepithelial transport of HIV-1 by intestinal M-cells: a mechanism for transmission of AIDS. Journal of Acquired Immune Deficiency Syndromes. 4:1991;760-765.
36. Sicinski P., Rowinski J., Warchol J.B., Jarzabek Z., Gut W., Szczygiel B., Bielecki K., Koch G. Poliovirus type 1 enters the human host through intestinal M-cells. Gastroenterology. 98:1990;56-58.
37. Mowat A.M., Viney J.L. The anatomical basis of intestinal immunity. Immunological Reviews. 156:1997;145-166.
38. de Aizpurua H.J., Russell-Jones G.J. Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. The Journal of Experimental Medicine. 167:1988;440-451.
39. Volpers C., Unckell F., Schirmacher P., Streeck R.E., Sapp M. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. Journal of Virology. 69:1995;3258-3264.
40. Müller M., Gissmann L., Cristiano R.J., Sun X.Y., Frazer I.H., Jenson A.B., Alonso A., Zentgraf H., Zhou J. Papillomavirus capsid binding and uptake by cells from different tissues and species. Journal of Virology. 69:1995;948-954.